Publications
- Mitochondrially targeted tamoxifen as anticancer therapy: case series of patients with renal cell carcinoma treated in a phase I/Ib clinical trial2023 | First Faculty of Medicine, Third Faculty of Medicine, Central Library of Charles University, Faculty of Science, Faculty of Mathematics and Physics
- Microbiota as the unifying factor behind the hallmarks of cancer2023 | First Faculty of Medicine
- Molecularly targeted treatment and the principle of agnostic therapy2022 | First Faculty of Medicine
- Multimodal approach in the treatment of generalized malignancies of the gastrointestinal tract2022 | First Faculty of Medicine
- New methodology of TMB assessment from tissue and liquid biopsy in NSCLC2022 | First Faculty of Medicine
- Future of lung cancer treatment2021 | First Faculty of Medicine
- Next generation sequencing and the molecular tumor board from the point of view of oncologists2021 | First Faculty of Medicine
- Estrogen Receptor Status Oppositely Modifies Breast Cancer Prognosis in BRCA1/BRCA2 Mutation Carriers Versus Non-Carriers2019 | First Faculty of Medicine, Third Faculty of Medicine
- Neuroendocrine tumors in cases2018 | First Faculty of Medicine
- Mitochondrially targeted tamoxifen in patients with metastatic solid tumours: an open-label, phase I/Ib single-centre trial2023 | First Faculty of Medicine, Third Faculty of Medicine, Central Library of Charles University, Faculty of Science, Faculty of Mathematics and Physics
Loading network view...
